Financial Statements

FibroGen, Inc. (FGEN)

$1.83

+0.12 (+7.02%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2023 2022 2021 2020 2019
Retained Earnings (Previous Year) -1,558-1,264-974-785-
Net Income -284-295-291-189-77
Stock Dividends 27811-695
Dividend Paid -2-5-7-11-13
Retained Earnings -1,842-1,558-1,264-974-785

PPE Schedule

Year 2023 2022 2021 2020 2019
Gross PPE 1001206382-
Annual Depreciation -171987-1588
Capital Expenditure -3-39-30-4-6
Net PPE 811001206382

Intangible and Goodwill Schedule

Year 2023 2022 2021 2020 2019
Intangible and Goodwill (Previous Year) -----
New Purchases -411-8-484-164-252
Intangible and Goodwill -----

FibroGen, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes FibroGen, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.